C-V2EWCosmica Biosciences
AI, multi-omics, aging biomarkers
discoverydiscovering
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-V2EW
C-V2EWC-V2EWAI, multi-omics, aging biomarkers
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Cosmica Biosciences AI, multi-omics, aging biomarkers
Cosmica Biosciences describes itself as the intelligence behind precision longevity. Its products include OrganAge, an organ-specific aging test, and BeyondAge, a system using simulated microgravity to forecast aging trajectory. The company says its intervention engine reads genes driving aging and ranks foods, supplements, and exercise through a gene-compound interactome.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Cosmica Biosciences — Far from goals · Bottom quartile. Derived deterministically from 3 extracted project(s). Most-advanced status: undisclosed. Band: far. Modifiers: +5 depth (2 programs at undisclosed).…
Source: Deterministic